Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Aura Biosciences to Participate in Upcoming Investor Conferences


Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced that members of its executive team will participate in the following upcoming investor conferences:

A live webcast of the Stifel presentation and Evercore ISI fireside chat will be available on the "Investors & Media" page under the "Events & Presentations" section of the Company's website at https://ir.aurabiosciences.com/events-and-presentations, where a replay of the webcasts will be archived for 90 days following the presentation date.

About Aura Biosciences

Aura Biosciences, Inc. is a clinical-stage biotechnology company developing virus-like drug conjugates (VDCs), a novel class of therapies, for the treatment of multiple oncology indications. Aura's lead VDC candidate, belzupacap sarotalocan (Bel-sar; AU-011), consists of a virus-like particle conjugated with an anti-cancer agent. Belzupacap sarotalocan is designed to selectively target and destroy cancer cells and activate the immune system with the potential to create long-lasting anti-tumor immunity. Belzupacap sarotalocan is currently in development for ocular cancers, with an ongoing Phase 2 dose escalation clinical trial evaluating first-line treatment of choroidal melanoma, a vision- and life-threatening form of eye cancer where standard of care with radiotherapy leaves patients with severe comorbidities, including major vision loss. Aura plans to pursue development of belzupacap sarotalocan across its ocular oncology franchise including for the treatment of patients with choroidal metastasis. In addition, leveraging Aura's technology platform, Aura is developing belzupacap sarotalocan more broadly across multiple cancers, including in patients with non-muscle invasive bladder cancer (NMIBC). Aura is headquartered in Boston, MA.

For more information, visit aurabiosciences.com, or follow us on Twitter and LinkedIn.


These press releases may also interest you

at 08:54
The World Perfumery Congress (WPC) Heads to Geneva, Switzerland in June
The World Perfumery Congress (WPC)?the premier global event for fragrance artistry, ingredients, technology and brands?will be hosted in Geneva, Switzerland, at the Palexpo June 24-27, 2024....

at 08:48
Steakholder Foods Welcomes Michal Ansky as Culinary Director and Special Strategic Consultant
Steakholder Foods, a leading innovator in alternative proteins and 3D printing technologies, is excited to announce the appointment of Michal Ansky as the newest addition to our team. Michal will serve as a consultant, bringing her extensive...

at 08:47
Wireless Trains and Fuel Economy - IDTechEx Explores the Potential Behind Electric and Zero-Emission Trains
Trains that could travel to more tucked-away parts of the country with zero emissions are an example of the potential behind battery electric (BEV) and fuel cell (FC) trains. The benefits to the environment, alongside businesses removing long-term...

at 08:45
ANNUAL REPORT 2023 ZINZINO AB (PUBL)
Zinzino (publ) announces that the company's annual report for 2023 in Swedish is now published on the company's website, zinzino.com. The English version will be published within approximately 45 days. The 2024 Annual General Meeting will be held at...

at 08:44
FirstHive Secures Investment in Latest Funding Round
FirstHive, the leading provider of customer data platform (CDP) solutions, has announced the closing of its latest funding round led by Saama with participation from Benhamou Global Ventures (BGV), Amit Singhal, and Twin Ventures. Notably, existing...

at 08:42
CoachRx Unveils RxBot: The Future of AI-Driven Fitness Coaching
CoachRx, a leader in innovative technology solutions for fitness professionals, is thrilled to announce the upcoming release of RxBot, a state-of-the-art AI coaching assistant poised to redefine the landscape of fitness coaching. Developed with the...

More news about Science and technology...


News published on and distributed by: